Literature DB >> 3514798

The biological modification of tumor cells as a means of inducing their regression: an overview.

H Kobayashi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514798

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN: 0732-6580


× No keyword cloud information.
  7 in total

Review 1.  Vectors for cancer gene therapy.

Authors:  J Zhang; S J Russell
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

2.  Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.

Authors:  H Schild; P von Hoegen; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Intensive study of the biology of brain tumors.

Authors:  L B Rorke
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia.

Authors:  J S Bryson; D C Cox
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.

Authors:  F Okada; M Hosokawa; J Hasegawa; M Ishikawa; I Chiba; Y Nakamura; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.

Authors:  M H Ravindranath; S M Brazeau; D L Morton
Journal:  Experientia       Date:  1994-07-15

7.  Preclinical HER-2 Vaccines: From Rodent to Human HER-2.

Authors:  Pier-Luigi Lollini; Carla De Giovanni; Patrizia Nanni
Journal:  Front Oncol       Date:  2013-06-10       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.